Colorectal Cancer Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health System's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality. The data presented below is included in the CoC's quality of care measures for colon and rectal cancer, and are for 2010, the most recent year for which data is available. (Data provided by the National Cancer Database.)

The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health System with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below meaures. For more information about quality and safety measures, see Quality Care.

Adjuvant chemotherapy considered within four months of diagnosis with AJCC Stage III (lymph node positive) colon cancer (when appropriate) - diagnosis year 2010

UC San Diego Health System 100%
State of California 88.2%
Pacific Region 90.8%
Teaching Hospitals 93.1%
All Commission on Cancer Approved Programs 92.9%

At least 12 regional lymph nodes removed and examined for resected colon cancer - diagnosis year 2010

UC San Diego Health System 100%
State of California 85.4%
Pacific Region 86.8%
Teaching Hospitals 90.5%
All Commission on Cancer Approved Programs 86.6%

Radiation therapy considered within 6 months of diagnosis for AJCC T4N0M0 or Stage III receiving surgical resection for rectal cancer - diagnosis year 2010

UC San Diego Health System 100%
State of California 89.4%
Pacific Region 90.6%
Teaching Hospitals 93.0%
All Commission on Cancer Approved Programs 92.5%